non-steroid glucocorticoid receptor modulator

completed Ph. I as topical agent in psoriasis

from optimization of prior lead

Bioorg. Med. Chem. Lett., Jun. 1, 2020

Bayer AG, Berlin, DE / AstraZeneca

BAY 1003803 is a potent topical agonist of the glucocorticoid receptor (GR) transrepression pathway, with less activity on the GR transactivation pathway mediated by GR dimers, which may lead to…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks